Potential Hepatoprotective Role of Galectin-3 during HCV Infection in End-Stage Renal Disease Patients

Figure 4

Galectin-3 and liver damage marker correlation. Correlations were analyzed between galectin-3 and markers of liver damage in the group of patients with end-stage renal disease and hepatitis C viral infection. Based on r value, correlation can be positive or negative and weak (), moderate (), and strong (). (a, b) Moderate negative correlation was obtained between galectin-3 and AST as well as galectin-3 and ALT in ESRD HCV⁺ patients.

(a)

(b)